VIKING GLOBAL INVESTORS LP - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 208 filers reported holding BRIDGEBIO PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.6%.

Quarter-by-quarter ownership
VIKING GLOBAL INVESTORS LP ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$662,440,533
+44.7%
25,120,991
-5.6%
2.69%
+43.4%
Q2 2023$457,881,045
+3.7%
26,620,9910.0%1.88%
-9.5%
Q1 2023$441,376,031
+117.6%
26,620,9910.0%2.07%
+104.0%
Q4 2022$202,851,951
-23.3%
26,620,9910.0%1.02%
-16.9%
Q3 2022$264,613,000
+9.5%
26,620,9910.0%1.22%
+10.5%
Q2 2022$241,719,000
-10.5%
26,620,9910.0%1.11%
+1.3%
Q1 2022$270,203,000
-39.1%
26,620,9910.0%1.09%
-14.6%
Q4 2021$444,038,000
-64.4%
26,620,9910.0%1.28%
-62.6%
Q3 2021$1,247,726,000
-23.1%
26,620,9910.0%3.42%
-30.4%
Q2 2021$1,622,816,000
-1.0%
26,620,9910.0%4.92%
+0.7%
Q1 2021$1,639,853,000
-13.4%
26,620,9910.0%4.88%
-6.2%
Q4 2020$1,893,019,000
+89.5%
26,620,9910.0%5.20%
+44.2%
Q3 2020$998,820,000
+15.1%
26,620,9910.0%3.61%
-3.8%
Q2 2020$868,111,000
+12.4%
26,620,9910.0%3.75%
-6.6%
Q1 2020$772,009,000
-17.3%
26,620,9910.0%4.02%
-8.1%
Q4 2019$933,066,000
+63.3%
26,620,9910.0%4.37%
+46.7%
Q3 2019$571,553,000
-20.4%
26,620,9910.0%2.98%
-7.6%
Q2 2019$717,968,00026,620,9913.22%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$55,099,00039.31%
M28 Capital Management LP 466,200$4,233,0004.74%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$282,034,0003.75%
Octagon Capital Advisors LP 933,743$8,478,0002.26%
VIKING GLOBAL INVESTORS LP 26,620,991$241,719,0001.11%
HHLR ADVISORS, LTD. 5,362,014$48,687,0001.04%
Cormorant Asset Management, LP 1,469,179$13,340,0001.01%
Knott David M Jr 213,206$1,936,0000.81%
Fernwood Investment Management, LLC 183,900$1,670,0000.72%
HighVista Strategies LLC 105,942$962,0000.58%
View complete list of BRIDGEBIO PHARMA INC shareholders